A carregar...

Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab

BACKGROUND: Treatment with infliximab induces a rapid therapeutic response in most patients with active rheumatoid arthritis. Factors predicting good response are not well known. OBJECTIVE: To study the predictive value of baseline level of soluble interleukin 2 receptor (sIL2R), a marker of lymphoc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kuuliala, A, Nissinen, R, Kautiainen, H, Repo, H, Leirisalo‐Repo, M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1797973/
https://ncbi.nlm.nih.gov/pubmed/15941839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.034728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!